Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 February 2023 | Story Kekeletso Takang | Photo Supplied
Michelle De Lange
UFS School of Accountancy Lecturer, Michelle de Lange, aced the recent Chartered Global Management Accountants Board exam, obtaining second position.

Michelle de Lange, accredited Accounting Lecturer in the School of Accountancy at the University of the Free State (UFS), finished second in the world at the recent Chartered Global Management Accountant (CGMA) Board Examination. With only one point between De Lange and the first candidate, she aced the challenging exam.    

Having obtained fourth position in the world for the 2019 CIMA Gateway exam, De Lange was determined to outdo herself.

The Chartered Institute of Management Accountants (CIMA) is the world’s largest global professional management accounting body to offer training and qualification in management accountancy. As designation holders, members get to showcase their skills and experience to a global audience, while upholding professionalism and promoting continuous learning. 

De Lange, who holds another professional accreditation from the South African Institute of Chartered Accountants (SAICA), coordinates the BCom Honours in Management Accounting programme, which is CIMA-aligned for postgraduate students. For De Lange, the greatest reward is the realisation of the impact she is making on her students through strategic vision.  

Having worked in the private sector and later joining the UFS as an Assistant Director at Finance back in 2016, De Lange believed that something was missing; that there was more to give. In 2018 she moved to the School of Accountancy, taking on her new role as Lecturer. “I wanted to make a difference and be significant. This motivated my move to lecturing,” she says. 

Her passion for teaching extends beyond the lecture hall. De Lange pays it forward by supporting students through a hands-on approach and ensuring that assessments are CIMA-aligned. 

The School of Accountancy in the Faculty of Economic and Management Sciences is proud of De Lange and her achievements. 

Becoming a CGMA requires discipline. De Lange is grateful for the support she received in preparation for the board exam, in particular from her husband Francois, who was “always understanding and encouraging”. 

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept